Global Halogenated Hydrocarbon General Anesthetics Market Growth 2024-2030

Publication ID:

LPI11243579

Publication Date:

November 8, 2024

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Halogenated hydrocarbon general anesthetics refer to hydrocarbon compounds containing halogens and are used for general anesthesia. These anesthetics enter the body by inhalation or intravenous injection, act in the central nervous system, inhibit nerve conduction, and thus cause general anesthesia with loss of consciousness and sensation.
The global Halogenated Hydrocarbon General Anesthetics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淗alogenated Hydrocarbon General Anesthetics Industry Forecast鈥� looks at past sales and reviews total world Halogenated Hydrocarbon General Anesthetics sales in 2023, providing a comprehensive analysis by region and market sector of projected Halogenated Hydrocarbon General Anesthetics sales for 2024 through 2030. With Halogenated Hydrocarbon General Anesthetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Halogenated Hydrocarbon General Anesthetics industry.
This Insight Report provides a comprehensive analysis of the global Halogenated Hydrocarbon General Anesthetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Halogenated Hydrocarbon General Anesthetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Halogenated Hydrocarbon General Anesthetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Halogenated Hydrocarbon General Anesthetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Halogenated Hydrocarbon General Anesthetics.
United States market for Halogenated Hydrocarbon General Anesthetics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Halogenated Hydrocarbon General Anesthetics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Halogenated Hydrocarbon General Anesthetics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Halogenated Hydrocarbon General Anesthetics players cover Hebei Yipin Pharmaceutical Co., Ltd., Shanghai Hengrui Medicine Co., Ltd., Hebei Sams Pharmaceutical Co., Ltd., Fujian Haixi United Pharmaceutical Co., Ltd., Shandong New Era Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Halogenated Hydrocarbon General Anesthetics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Enflurane
Desflurane
Sevoflurane
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hebei Yipin Pharmaceutical Co., Ltd.
Shanghai Hengrui Medicine Co., Ltd.
Hebei Sams Pharmaceutical Co., Ltd.
Fujian Haixi United Pharmaceutical Co., Ltd.
Shandong New Era Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Piramal Critical Care
AbbVie
Baxter
Halocarbon
Key Questions Addressed in this Report
What is the 10-year outlook for the global Halogenated Hydrocarbon General Anesthetics market?
What factors are driving Halogenated Hydrocarbon General Anesthetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Halogenated Hydrocarbon General Anesthetics market opportunities vary by end market size?
How does Halogenated Hydrocarbon General Anesthetics break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Halogenated Hydrocarbon General Anesthetics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Halogenated Hydrocarbon General Anesthetics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Halogenated Hydrocarbon General Anesthetics by Country/Region, 2019, 2023 & 2030
2.2 Halogenated Hydrocarbon General Anesthetics Segment by Type
2.2.1 Enflurane
2.2.2 Desflurane
2.2.3 Sevoflurane
2.3 Halogenated Hydrocarbon General Anesthetics Sales by Type
2.3.1 Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2019-2024)
2.3.2 Global Halogenated Hydrocarbon General Anesthetics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Halogenated Hydrocarbon General Anesthetics Sale Price by Type (2019-2024)
2.4 Halogenated Hydrocarbon General Anesthetics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Halogenated Hydrocarbon General Anesthetics Sales by Application
2.5.1 Global Halogenated Hydrocarbon General Anesthetics Sale Market Share by Application (2019-2024)
2.5.2 Global Halogenated Hydrocarbon General Anesthetics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Halogenated Hydrocarbon General Anesthetics Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Halogenated Hydrocarbon General Anesthetics Breakdown Data by Company
3.1.1 Global Halogenated Hydrocarbon General Anesthetics Annual Sales by Company (2019-2024)
3.1.2 Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Company (2019-2024)
3.2 Global Halogenated Hydrocarbon General Anesthetics Annual Revenue by Company (2019-2024)
3.2.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Company (2019-2024)
3.2.2 Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Company (2019-2024)
3.3 Global Halogenated Hydrocarbon General Anesthetics Sale Price by Company
3.4 Key Manufacturers Halogenated Hydrocarbon General Anesthetics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Halogenated Hydrocarbon General Anesthetics Product Location Distribution
3.4.2 Players Halogenated Hydrocarbon General Anesthetics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Halogenated Hydrocarbon General Anesthetics by Geographic Region
4.1 World Historic Halogenated Hydrocarbon General Anesthetics Market Size by Geographic Region (2019-2024)
4.1.1 Global Halogenated Hydrocarbon General Anesthetics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Halogenated Hydrocarbon General Anesthetics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Halogenated Hydrocarbon General Anesthetics Market Size by Country/Region (2019-2024)
4.2.1 Global Halogenated Hydrocarbon General Anesthetics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Halogenated Hydrocarbon General Anesthetics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Halogenated Hydrocarbon General Anesthetics Sales Growth
4.4 APAC Halogenated Hydrocarbon General Anesthetics Sales Growth
4.5 Europe Halogenated Hydrocarbon General Anesthetics Sales Growth
4.6 Middle East & Africa Halogenated Hydrocarbon General Anesthetics Sales Growth
5 Americas
5.1 Americas Halogenated Hydrocarbon General Anesthetics Sales by Country
5.1.1 Americas Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2024)
5.1.2 Americas Halogenated Hydrocarbon General Anesthetics Revenue by Country (2019-2024)
5.2 Americas Halogenated Hydrocarbon General Anesthetics Sales by Type (2019-2024)
5.3 Americas Halogenated Hydrocarbon General Anesthetics Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Halogenated Hydrocarbon General Anesthetics Sales by Region
6.1.1 APAC Halogenated Hydrocarbon General Anesthetics Sales by Region (2019-2024)
6.1.2 APAC Halogenated Hydrocarbon General Anesthetics Revenue by Region (2019-2024)
6.2 APAC Halogenated Hydrocarbon General Anesthetics Sales by Type (2019-2024)
6.3 APAC Halogenated Hydrocarbon General Anesthetics Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Halogenated Hydrocarbon General Anesthetics by Country
7.1.1 Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2024)
7.1.2 Europe Halogenated Hydrocarbon General Anesthetics Revenue by Country (2019-2024)
7.2 Europe Halogenated Hydrocarbon General Anesthetics Sales by Type (2019-2024)
7.3 Europe Halogenated Hydrocarbon General Anesthetics Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Halogenated Hydrocarbon General Anesthetics by Country
8.1.1 Middle East & Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Halogenated Hydrocarbon General Anesthetics Revenue by Country (2019-2024)
8.2 Middle East & Africa Halogenated Hydrocarbon General Anesthetics Sales by Type (2019-2024)
8.3 Middle East & Africa Halogenated Hydrocarbon General Anesthetics Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Halogenated Hydrocarbon General Anesthetics
10.3 Manufacturing Process Analysis of Halogenated Hydrocarbon General Anesthetics
10.4 Industry Chain Structure of Halogenated Hydrocarbon General Anesthetics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Halogenated Hydrocarbon General Anesthetics Distributors
11.3 Halogenated Hydrocarbon General Anesthetics Customer
12 World Forecast Review for Halogenated Hydrocarbon General Anesthetics by Geographic Region
12.1 Global Halogenated Hydrocarbon General Anesthetics Market Size Forecast by Region
12.1.1 Global Halogenated Hydrocarbon General Anesthetics Forecast by Region (2025-2030)
12.1.2 Global Halogenated Hydrocarbon General Anesthetics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Halogenated Hydrocarbon General Anesthetics Forecast by Type (2025-2030)
12.7 Global Halogenated Hydrocarbon General Anesthetics Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Hebei Yipin Pharmaceutical Co., Ltd.
13.1.1 Hebei Yipin Pharmaceutical Co., Ltd. Company Information
13.1.2 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.1.3 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Hebei Yipin Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Hebei Yipin Pharmaceutical Co., Ltd. Latest Developments
13.2 Shanghai Hengrui Medicine Co., Ltd.
13.2.1 Shanghai Hengrui Medicine Co., Ltd. Company Information
13.2.2 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.2.3 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Shanghai Hengrui Medicine Co., Ltd. Main Business Overview
13.2.5 Shanghai Hengrui Medicine Co., Ltd. Latest Developments
13.3 Hebei Sams Pharmaceutical Co., Ltd.
13.3.1 Hebei Sams Pharmaceutical Co., Ltd. Company Information
13.3.2 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.3.3 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hebei Sams Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Hebei Sams Pharmaceutical Co., Ltd. Latest Developments
13.4 Fujian Haixi United Pharmaceutical Co., Ltd.
13.4.1 Fujian Haixi United Pharmaceutical Co., Ltd. Company Information
13.4.2 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.4.3 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Fujian Haixi United Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Fujian Haixi United Pharmaceutical Co., Ltd. Latest Developments
13.5 Shandong New Era Pharmaceutical Co., Ltd.
13.5.1 Shandong New Era Pharmaceutical Co., Ltd. Company Information
13.5.2 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.5.3 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shandong New Era Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Shandong New Era Pharmaceutical Co., Ltd. Latest Developments
13.6 Sichuan Baili Pharmaceutical Co., Ltd.
13.6.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
13.6.2 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.6.3 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sichuan Baili Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Sichuan Baili Pharmaceutical Co., Ltd. Latest Developments
13.7 Lunan Beite Pharmaceutical Co., Ltd.
13.7.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
13.7.2 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.7.3 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lunan Beite Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Lunan Beite Pharmaceutical Co., Ltd. Latest Developments
13.8 Piramal Critical Care
13.8.1 Piramal Critical Care Company Information
13.8.2 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.8.3 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Piramal Critical Care Main Business Overview
13.8.5 Piramal Critical Care Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.9.3 AbbVie Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Baxter
13.10.1 Baxter Company Information
13.10.2 Baxter Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.10.3 Baxter Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Baxter Main Business Overview
13.10.5 Baxter Latest Developments
13.11 Halocarbon
13.11.1 Halocarbon Company Information
13.11.2 Halocarbon Halogenated Hydrocarbon General Anesthetics Product Portfolios and Specifications
13.11.3 Halocarbon Halogenated Hydrocarbon General Anesthetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Halocarbon Main Business Overview
13.11.5 Halocarbon Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂